Microbial keratitis secondary to infection with Citrobacter koseri.
Goold
Lucy A
LA
Warrier
Sunil K
SK
Wittles
Nadia K
NK
Nathan
Francis
F
D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000068438:Brimonidine Tartrate; D002437:Cefazolin / Q000627:therapeutic use; D041041:Citrobacter koseri / Q000302:isolation & purification*; D003320:Corneal Ulcer / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D004359:Drug Therapy, Combination; D004756:Enterobacteriaceae Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D015818:Eye Infections, Bacterial / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D011810:Quinoxalines / Q000627:therapeutic use; D013999:Timolol / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D011810:Quinoxalines; D000068438:Brimonidine Tartrate; D013999:Timolol; D002437:Cefazolin